Sectoral/ ThematicUTI Asset Mgmt. Co. Ltd.

UTI Healthcare Fund - Direct Plan - Growth Option

Benchmark: BSE Healthcare TRI · Riskometer: Very High

₹392.7383

NAV (2026-08-31)

₹1,443.569 Cr

AUM (2026-08-31)

1.26%

EXPENSE RATIO (DIRECT)

1999-05-27

INCEPTION

CQuality · 59.8/100

BSafety · 79.3/100

BCompound · 71.9/100

Punji Fund Health Score - percentile-within-category. See methodology.

CHART

Rolling CAGR by holding period - min, median, max

Each group is one holding-period length. Full range of outcomes across every overlapping window in the fund's history, not one trailing number.

Min rolling CAGRMedian rolling CAGRMax rolling CAGR

Category RankRisk MetricsHoldingsSimilar FundsPunji Analytics

Metric	Value	Percentile	Category median
3Y Rolling CAGR	17.7%	53.4^th	17.5%
3Y Sharpe Ratio	1.32	98.2^th	0.63
3Y Alpha	3.6%	60^th	2.7%
3Y Std Deviation	13.9%	69.37^th (lower is better)	15.0%

1.322

2.0044

3.5551

0.8869

13.892

-15.879

93.2982

85.1795

4.2869

Tracking Error (%)

1.5905

Calmar Ratio

3-year window vs. BSE Healthcare TRI.

CHART

Top sector holdings

Share of portfolio (% to NAV) in each of the top sectors.

Other 99.07%

TOP HOLDINGS

SUN PHARMACEUTICALS INDUSTRIES ()8.71%

DIVIS LABORATORIES LTD. ()5.57%

AJANTA PHARMA LTD. ()4.8%

CAPLIN POINT LABORATORIES LTD ()3.95%

LUPIN LTD. ()3.59%

GLAND PHARMA LTD. ()3.56%

APOLLO HOSPITALS ENTERPRISE LT ()3.46%

DR REDDYS LABORATORIES LTD. ()3.1%

ALKEM LABORATORIES LTD ()3.1%

NET CURRENT ASSETS ()2.9%

Funds that behave most similarly (beta, capture ratios, volatility - not holdings overlap). Pick up to 2 to compare alongside this fund:

31.63

P/E Ratio

5.65

P/B Ratio

0.52

Dividend Yield (%)

CHART

Asset Allocation

As of Jul-2026

Equity 96.15%Debt 0%Cash 2.92%

CHART

Market Cap Split

As of Jul-2026

Large 26%Mid 24%Small 51%

Portfolio analytics as of Jul-2026.

Data as of 2026-09-02. Source: AMFI disclosures via Punji. Not investment advice.